According to ACR suggestions, allopurinol is strongly advised as a first-line urate-decreasing medication. Genetic screening is recommended (for just a variant called HLA B*5801) before setting up allopurinol as the carriers of the gene are at a heightened threat of a intense allergic reaction. W